Business Description
Connect Biopharma Holdings Ltd
ISIN : US2075231017
Share Class Description:
CNTB: ADRDescription
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 339 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 21.7 | |||||
| 3-Year EPS without NRI Growth Rate | -26.8 | |||||
| 3-Year FCF Growth Rate | -19.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.71 | |||||
| 9-Day RSI | 47 | |||||
| 14-Day RSI | 44.68 | |||||
| 6-1 Month Momentum % | -32.67 | |||||
| 12-1 Month Momentum % | 5.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.04 | |||||
| Quick Ratio | 12.04 | |||||
| Cash Ratio | 11.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.7 | |||||
| Shareholder Yield % | 0.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -109.85 | |||||
| Net Margin % | -88.66 | |||||
| FCF Margin % | -104.45 | |||||
| ROE % | -18.88 | |||||
| ROA % | -16.45 | |||||
| ROIC % | -269.9 | |||||
| ROC (Joel Greenblatt) % | -444.65 | |||||
| ROCE % | -18.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.73 | |||||
| PS Ratio | 2.4 | |||||
| PB Ratio | 0.52 | |||||
| Price-to-Tangible-Book | 0.52 | |||||
| EV-to-EBIT | 2.65 | |||||
| EV-to-EBITDA | 2.77 | |||||
| EV-to-Revenue | -2.33 | |||||
| EV-to-FCF | 2.23 | |||||
| Price-to-Net-Current-Asset-Value | 0.54 | |||||
| Price-to-Net-Cash | 0.57 | |||||
| Earnings Yield (Greenblatt) % | 37.74 | |||||
| FCF Yield % | -44.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CNTB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Connect Biopharma Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 24.116 | ||
| EPS (TTM) ($) | -0.39 | ||
| Beta | -0.16 | ||
| Volatility % | 84.25 | ||
| 14-Day RSI | 44.68 | ||
| 14-Day ATR ($) | 0.09604 | ||
| 20-Day SMA ($) | 1.07069 | ||
| 12-1 Month Momentum % | 5.8 | ||
| 52-Week Range ($) | 0.6777 - 2.66 | ||
| Shares Outstanding (Mil) | 55.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Connect Biopharma Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Connect Biopharma Holdings Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Connect Biopharma Holdings Ltd Frequently Asked Questions
What is Connect Biopharma Holdings Ltd(CNTB)'s stock price today?
The current price of CNTB is $1.03. The 52 week high of CNTB is $2.66 and 52 week low is $0.68.
When is next earnings date of Connect Biopharma Holdings Ltd(CNTB)?
The next earnings date of Connect Biopharma Holdings Ltd(CNTB) is 2025-04-16 Est..
Does Connect Biopharma Holdings Ltd(CNTB) pay dividends? If so, how much?
Connect Biopharma Holdings Ltd(CNTB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers